- Home
- ZURA vs BRIA Comparison
ZURA vs BRIA Comparison
Compare ZURA & BRIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- BRIA
- Stock Information
- Founded
- ZURA 2022
- BRIA 2011
- Country
- ZURA United States
- BRIA Singapore
- Employees
- ZURA N/A
- BRIA N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- BRIA
- Sector
- ZURA Health Care
- BRIA
- Exchange
- ZURA Nasdaq
- BRIA NYSE
- Market Cap
- ZURA 69.9M
- BRIA 62.0M
- IPO Year
- ZURA N/A
- BRIA 2024
- Fundamental
- Price
- ZURA $1.30
- BRIA $2.46
- Analyst Decision
- ZURA Buy
- BRIA
- Analyst Count
- ZURA 7
- BRIA 0
- Target Price
- ZURA $14.33
- BRIA N/A
- AVG Volume (30 Days)
- ZURA 689.3K
- BRIA 2.3K
- Earning Date
- ZURA 08-08-2025
- BRIA 08-15-2025
- Dividend Yield
- ZURA N/A
- BRIA N/A
- EPS Growth
- ZURA N/A
- BRIA N/A
- EPS
- ZURA N/A
- BRIA 92.24
- Revenue
- ZURA N/A
- BRIA $59,695,825.00
- Revenue This Year
- ZURA N/A
- BRIA N/A
- Revenue Next Year
- ZURA N/A
- BRIA N/A
- P/E Ratio
- ZURA N/A
- BRIA $0.02
- Revenue Growth
- ZURA N/A
- BRIA 8.03
- 52 Week Low
- ZURA $0.97
- BRIA $1.78
- 52 Week High
- ZURA $5.07
- BRIA $4.38
- Technical
- Relative Strength Index (RSI)
- ZURA 58.73
- BRIA N/A
- Support Level
- ZURA $1.00
- BRIA N/A
- Resistance Level
- ZURA $1.45
- BRIA N/A
- Average True Range (ATR)
- ZURA 0.10
- BRIA 0.00
- MACD
- ZURA 0.02
- BRIA 0.00
- Stochastic Oscillator
- ZURA 66.67
- BRIA 0.00
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.